Differential dynamics of splicing factor SC35 during the cell cycle by Tripathi, Kaushlendra & Parnaik, Veena K.
Dynamics of splicing factor SC35 345
J. Biosci. 33(3), September 2008
1. Introduction
The nucleus is compartmentalized into specifi c protein-rich 
domains such as the nucleolus, nuclear speckles or splicing 
factor compartments, Cajal bodies and promyelocytic 
leukaemia bodies (reviewed by Lamond and Earnshaw 
1998; Spector 2003). In mammalian cells, pre-mRNA 
splicing factors are enriched in 20–50 nuclear speckles that 
correspond to interchromatin granule clusters (IGCs) at the 
electron microscopic level, and are also distributed in the 
nucleoplasm at the sites of transcription on perichromatin 
fi brils (reviewed by Fakan and Puvion 1980; Spector 
1993; Fakan 1994; Lamond and Spector 2003). The major 
constituents of IGCs are factors involved in RNA processing 
such as small nuclear ribonucleoproteins (snRNPs) and 
arginine–serine-rich (RS) splicing factors in mammalian 
cells (Mintz et al 1999). Nuclear speckles are dynamic 
structures that are involved in the spatial coordination of 
transcription and splicing (Misteli and Spector 1999; Sacco-
Bubulya and Spector 2002). Upon gene activation, splicing 
factors are recruited to transcription sites (Misteli et al 1997) 
and conversely coalesce to form enlarged foci in the presence 
of transcriptional inhibitors (Carmo-Fonseca et al 1992; 
Misteli et al 1997). The interphase dynamics of speckles 
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is controlled by the phosphorylation of splicing factors at 
RS domains. RS domains are specifi cally phosphorylated 
by a number of kinases such as Cdc2-like kinase (Clk/STY 
kinase) (Ben-David et al 1991; Howell et al 1991; Johnson 
and Smith 1991) and serine/arginine-rich protein kinase 1 
(SRPK1) (Gui et al 1994), leading to recruitment of splicing 
factors to the sites of transcription (Misteli et al 1998). 
Overexpression of Clk/STY kinase or SRPK1 causes 
dispersal of speckles in the nucleoplasm in interphase cells 
and disrupts the coordination between transcription and 
splicing (Gui et al 1994; Colwill et al 1996; Sacco-Bubulya 
and Spector 2002). Other kinases such as cyclin-dependent 
kinase (cdk)-9, cyclin T and CrkRS, which are involved in 
phosphorylation of the C-terminal domain of the largest 
subunit of RNA polymerase II, are localized in the vicinity 
of speckles (Herrmann and Mancini 2001; Ko et al 2001). 
During mitosis, nuclear speckles are disassembled by 
metaphase and reassembled in telophase in cytoplasmic 
structures termed mitotic interchromatin granules (MIGs), 
based on their similarity to IGCs in composition and 
granular appearance (Reuter et al 1985; Verheijen et al 
1986; Leser et al 1989; Spector et al 1991; Ferreira et al 
1994). After formation of the nascent nuclear envelope 
in telophase, there is sequential nuclear import of RNA 
polymerase II and transcription factors, followed by entry 
of pre-mRNA splicing factors; certain splicing factors such 
as SF2/alternate splicing factor (ASF) and B” remain highly 
enriched in MIGs till late telophase (Prasanth et al 2003). 
Although the dynamics of SF2/ASF in interphase cells has 
been well documented (Phair and Misteli 2000; Kruhlak et 
al 2000), the dynamics of splicing factors at different stages 
of mitosis have not been reported. 
In the present study, we analysed the localization and 
dynamics of the splicing factor SC35 in HeLa cells expressing 
GFP-SC35. The localization of GFP-SC35 in interphase and 
mitotic cells was determined with respect to markers for 
nuclear components. The mobility of GFP-SC35 was studied 
in different compartments in live cells by fl uorescence 
recovery after photobleaching (FRAP) experiments. Cells 
were treated with inhibitors of cdks to determine their 
effects on the organization of nuclear compartments such as 
nuclear speckles and nucleoli, and on the dynamics of GFP-
SC35 and the nucleolar protein GFP-fi brillarin. Our results 
indicate that the dynamics of GFP-SC35 are dependent on 
the organization of the compartment in which it is localized 
during the interphase and mitotic phase of the cell cycle.
2. Materials and methods
2.1 Plasmid constructs
A mouse cDNA for SC35 (provided by Tom Maniatis, 
Harvard University, Cambridge, MA, USA) was cloned into 
EcoRI/SalI-digested pEGFP-C2 vector to generate GFP-
SC35. A GST-SC35 fusion construct was made by cloning 
SC35 cDNA into SmaI/EcoRI-digested pGEX vector. 
GFP-SF2/ASF was obtained from Adrian Krainer (CSHL, 
Cold Spring Harbor, NY, USA) and GFP-fi brillarin was 
provided by Sui Huang (Northwestern University, Chicago, 
IL, USA).
2.2 Cell culture, DNA transfection and drug treatment
HeLa cells were routinely grown in DMEM supplemented 
with 10% foetal bovine serum (FBS) at 37°C in a humidifi ed 
atmosphere containing 5% CO
2
. A HeLa cell line stably 
expressing GFP-SC35 was generated by electroporation 
of the GFP-SC35 fusion construct, and maintained in 
DMEM (low glucose) with 10% FBS and 0.5 mg/ml G418 
(Invitrogen, Carlsbad, USA). GFP-fi brillarin or GFP-SF2/
ASF constructs were transiently transfected into HeLa cells 
using Lipofectamine 2000 according to the manufacturer’s 
instructions (Invitrogen). Roscovitine, olomoucine and 
iso-olomoucine were obtained from Calbiochem (Merck 
Chemicals, Darmstadt, Germany). Roscovitine was also 
provided by L Meijer (Station Biologique, Roscoff, France). 
HeLa cells were treated with 25 µM roscovitine for 1.5 h, or 
with 250 µM olomoucine or iso-olomoucine for 2 h. 
2.3 Antibodies and western blot analysis
A mouse monoclonal antibody (mAb) to SC35 was obtained 
from Sigma Chemical Co. (St Louis, USA). A mouse mAb 
to emerin (clone 4G5) was obtained from Novocastra 
Laboratories (Newcastle-upon-Tyne, UK). Polyclonal 
antibodies to fi brillarin and GFP were from Santa Cruz 
Biotechnology (Santa Cruz, USA) and Clontech (Palo Alto, 
USA), respectively. A mouse mAb to B” was a gift from 
David Spector (CSHL, Cold Spring Harbor, NY, USA). For 
western blot analysis, cells were harvested, lysed in Laemmli 
sample buffer, boiled and electrophoresed through sodium 
dodecyl sulphate (SDS)-10% polyacrylamide gels. Gels 
were electroblotted onto polyvinylidene fl uoride (PVDF) 
membrane fi lters and blocked overnight in 5% BLOTTO 
milk powder in Tris-buffered saline containing 0.1% Tween-
20. Filters were incubated with primary antibody for 2 h, 
followed by peroxidase-conjugated secondary antibody 
in Tris-buffered saline containing 0.1% Tween-20 for 1 h. 
Bound antibody was visualized using a chemiluminescence 
kit from Roche Applied Science (Mannheim, Germany). 
2.4 Immunofl uorescence microscopy
HeLa cells were washed with phosphate-buffered saline 
(PBS) and then fi xed with 4% formaldehyde in PBS for 
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10 min followed by 0.5% (vol/vol) Triton X-100 for 6 min 
at room temperature. Cells were then incubated with 0.5% 
gelatin in PBS for 1 h followed by incubation with primary 
antibody for 1 h and then Cy3-conjugated second antibody 
for 1 h at room temperature for single labelling experiments. 
For double labelling experiments, fi xed cells were incubated 
with the fi rst primary antibody followed by the biotinylated 
second antibody and avidin-Cy3, and then with the next 
primary antibody and species/subtype-specifi c fl uorescein 
isothiocyanate (FITC)-conjugated second antibody. 
Samples were mounted in Vectashield (Vector Laboratories, 
Burlingame, USA) containing 1 µg/ml 4′,6-diamidino-2-
phenylindole (DAPI). There was no cross-reactivity of the 
fl uorescent second antibodies in control experiments in 
which either primary antibody was omitted. Fluorescence 
microscopy was performed on an LSM510 META confocal 
microscope. Images were analysed with LSM 510 META 
software and assembled using Photoshop 6.0.
2.5 Live cell microscopy
HeLa cells stably expressing GFP-SC35 (or transiently 
expressing GFP-fi brillarin or GFP-SF2/ASF) were seeded 
on a LabTekII chamber slide and grown for 24 h. FRAP 
experiments were performed on an LSM510 inverted 
confocal microscope with a 63x/1.4 NA planapochromat 
water objective lens. A spot 1 µm in radius was bleached 
for 0.5 s using the 488 nm laser line at 100% laser power, 
and a series of images were acquired at 1 s intervals 
immediately after bleaching. Image acquisition was at low 
laser power, which did not signifi cantly affect fl uorescence 
intensity. Recovery of fl uorescence was observed till 100 s. 
All intensities were background subtracted for calculating 
the FRAP curves, which represented an average of 12–15 
individual cells bleached under identical conditions in 
at least three independent experiments (cells expressing 
moderate levels of GFP-SC35 were chosen for analysis). To 
normalize for loss of fl uorescence signal due to the bleach 
pulse and potential artifactual bleaching of GFP during the 
imaging scans, recovery intensities were normalized to the 
total fl uorescence signal at each time point. Cells exhibiting 
a loss of signal of more than 10% during the imaging phase 
were discarded from analysis. The relative fl uorescence 
intensity (RFI) at each time point was calculated as 
described by Phair and Misteli (2000), using the equation 
RFI = (It/Tt)/(I
0
/T
0
), where I
0
 and It are the average intensity 
of the region of interest before and after bleaching at 
time t, and T
0
 and Tt are the total intensity in the nucleus 
before and after bleaching at time t, respectively. The half-
time of fl uorescence recovery (t½) was calculated as half 
the time required for complete recovery of fl uorescence 
after bleaching. Diffusion coeffi cients were calculated 
by classical FRAP analysis as described by Axelrod et al 
(1976). Non-linear curve fi tting was carried out using Origin 
7.0. In control experiments with formaldehyde-fi xed cells, 
no recovery of fl uorescence was observed. 
2.6 Phosphorylation of recombinant GST-SC35
Recombinant GST-SC35 was expressed in E. coli 
BL21(DE3)-plys(S) by induction with 1 mM isopropyl-β-
D-thiogalactopyranoside (IPTG) for 3 h at 30°C and purifi ed 
on glutathione–agarose beads. The purity and quantity of 
the recombinant protein was determined by analysis on an 
SDS-polyacrylamide gel electrophoresis (PAGE) gel stained 
with Coomassie blue. Recombinant GST-SC35 protein was 
incubated for 30 min at 30°C with 5 µCi of γ32P-ATP, 100 µM 
ATP, 5 mM MgCl
2
, and 40 U of human Cdk1-cyclin B (New 
England Biolabs, Beverly, USA) in 20 µl of MEM buffer 
(100 mM Mes, pH 6.7, 1 mM EGTA, 1 mM MgCl
2
, 0.1 mM 
dithiothreitol). A control reaction was performed with kinase 
storage buffer instead of enzyme. Phosphorylation reactions 
were stopped with Laemmli buffer supplemented with 10 
mM EDTA and samples were processed for SDS-PAGE, 
followed by analysis of the same gel on a phosphorimager 
(Molecular Imager FX, Bio-Rad, Hercules, USA).
3. Results
3.1 Localization of GFP-SC35 in interphase and 
mitotic cells
Splicing factor compartments comprise ~150 proteins, which 
include both snRNP proteins and non-snRNP proteins such 
as SC35 and SF2/ASF (Mintz et al 1999). In order to study 
the dynamics of the splicing factor SC35 during mitosis, 
we produced a stable HeLa cell line expressing GFP-SC35. 
The rates of cell division and viability of the parental HeLa 
cell line and GFP-SC35 stable clone were observed to be 
similar. Western blot analysis with antibodies to GFP and 
SC35 indicated that GFP-SC35 migrated at the appropriate 
mobility and was expressed at low levels compared with 
endogenous SC35 (fi gure 1A). The distribution of GFP-SC35 
was initially confi rmed by fl uorescence microscopy with 
fi xed cells (fi gure 1B). In interphase cells, GFP-SC35 was 
distributed in a speckled pattern as well as a diffuse nuclear 
location, as described previously for fl uorescent-tagged 
SC35 (Prasanth et al 2003; Politz et al 2006). At the onset of 
mitosis, GFP-SC35 speckles became dispersed in metaphase 
cells. From metaphase to anaphase, GFP-SC35 was mostly 
diffusely distributed, though an occasional speckle could be 
detected. In telophase cells, a substantial fraction of GFP-
SC35 was observed within daughter nuclei. The remainder 
was concentrated in speckles corresponding to MIGs outside 
the nuclei. The interphase pattern of speckles was restored in 
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early G1 cells. These experiments indicate that GFP-SC35 
is a suitable marker for the physiological functions and 
distribution of SC35.
The sequence of GFP-SC35 localization at different 
stages of mitosis was investigated with respect to 
endogenous nuclear markers. The localization of GFP-SC35 
in distinct domains was analysed with a widely-used mAb 
to SC35, which recognizes a specifi c hyperphosphorylated 
form of SC35 present in speckles in interphase cells and 
in MIGs in mitotic cells, but is absent in metaphase cells 
and telophase nuclei (Fu and Maniatis 1990). Moreover, 
this antibody to phosphorylated SC35 would recognize 
the endogenous protein, which is more abundant in the 
cells. In interphase cells, GFP-SC35 was localized in 
nuclear speckles which were stained by the antibody to 
SC35. However, the antibody did not detect GFP-SC35 
in metaphase cells or telophase nuclei, though it stained 
MIGs in telophase cells, which also harboured GFP-SC35 
(fi gure 2A). The number of MIGs increased from anaphase 
to telophase and decreased subsequently. SC35 has been 
earlier detected in a diffuse distribution in metaphase cells 
(Prasanth et al 2003) and within telophase nuclei with an 
antibody to hypophosphorylated SC35 (Bubulya et al 2004). 
An antibody to the U2 snRNP protein B” labelled nuclear 
speckles containing GFP-SC35 in interphase cells (fi gure 
2B). Like other snRNPs, B” was also localized in Cajal 
bodies as reported earlier (Prasanth et al 2003), but these 
structures did not contain GFP-SC35. B” was diffusely 
distributed in metaphase cells and concentrated in MIGs in 
telophase cells, where it colocalized with GFP-SC35. The 
major fraction of GFP-SC35 and a small amount of B” were 
located in telophase nuclei. 
Earlier studies have demonstrated that SF2/ASF enters 
telophase nuclei only after the formation of a functional 
nuclear envelope (Prasanth et al 2003). To confi rm that 
nuclear envelope formation had been initiated when GFP-
SC35 was detectable in telophase nuclei, cells were labelled 
with an antibody to the inner nuclear membrane protein, 
emerin. As shown in fi gure 2C, emerin displayed a distinct 
localization in the nuclear envelope in interphase cells 
but was dispersed during metaphase when the envelope 
breaks down. During telophase, emerin was localized at 
the nascent envelope of telophase nuclei harbouring GFP-
SC35. We also determined the distribution of GFP-SC35 
with respect to the nucleolar marker fi brillarin (fi gure 2D). 
In interphase cells, GFP-SC35 and fi brillarin occupied 
distinct compartments as expected. During metaphase, both 
GFP-SC35 and fi brillarin were dispersed. In early telophase 
nuclei, small foci of fi brillarin were observed, which are 
likely to be pre-nucleolar bodies (Scheer and Hock 1999), 
and these domains were surrounded by GFP-SC35 but did 
not colocalize with it, consistent with the data for SF2/ASF 
(Bubulya et al 2004). 
3.2 Dynamics of GFP-SC35 in different compartments
To determine the dynamic behaviour of GFP-SC35, FRAP 
experiments were carried out with HeLa cells stably 
transfected with GFP-SC35. The mobility of GFP-SC35 
Figure 1. Expression of green fl uorescent protein (GFP)-SC35 and localization during mitosis. (A) Whole cell lysates of untransfected 
(U) and GFP-SC35-transfected (T) HeLa cells were analysed by western blotting with antibodies to SC35 and GFP. Positions of GFP-
SC35 and SC35 (major species) are indicated by an arrow and arrowhead, respectively. This mouse antibody (mAb) to SC35 also labels 
other differentially phosphorylated forms of SC35. An asterisk points to a non-specifi c band observed in both untransfected and transfected 
cell lysates. Molecular mass markers (kD): albumin, 67 kD; ovalbumin, 45 kD; and carbonic anhydrase, 30 kD. (B) Mitotic HeLa cells 
expressing GFP-SC35 were observed at different phases of mitosis by confocal microscopy (optical sections of 0.5 µm). Arrows indicate 
GFP-SC35 in speckles outside the telophase nucleus. Bar, 5 µm. 
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was analysed in different compartments in interphase and 
mitotic cells. A spot with a radius of 1 µm over a speckle 
or in the nucleoplasm was photobleached. Subsequently, 
the RFI within the photobleached area was measured. The 
fl uorescence recovery curves were analysed as described 
(Phair and Misteli 2000). Representative FRAP curves and 
scanned images of bleached cells are shown in fi gure 3. 
Bleaching conditions were optimized for 40–60% bleach 
as per standard procedures. FRAP analyses revealed that 
GFP-SC35 had a half-time of fl uorescence recovery (t½) 
of ~2 s with a diffusion coeffi cient of 0.24 µm2/s in both 
interphase nuclear speckles and the nucleoplasm, with nearly 
90% recovery observed at 30 s (fi gure 3 and table 1). Similar 
values were obtained for GFP-SF2/ASF in transiently 
transfected cells and these values closely correspond to 
those reported in earlier studies with GFP-SF2/ASF (Phair 
and Misteli 2000). FRAP data of GFP-SC35 in MIGs in 
telophase cells were also similar to that of normal interphase 
Figure 2. Localization of green fl uorescent protein (GFP)-SC35 with respect to nuclear markers. Mitotic HeLa cells expressing GFP-
SC35 were stained with antibodies to (A) SC35, (B) B”, (C) emerin and (D) fi brillarin (optical sections of 0.5 µm). Arrows indicate GFP-
SC35 speckles outside telophase nuclei that are colocalized with SC35 and B”. 4′,6-diamidino-2-phenylindole (DAPI) staining is shown in 
the insets. Bar, 10 µm.
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cells. Interestingly, the recovery of fl uorescence from GFP-
SC35 distributed diffusely in the cytoplasm of metaphase 
cells was 3-fold faster than that in speckles or interphase 
nucleoplasm (P<0.001) and recovery had already occurred 
while scanning the image of the bleached cell in fi gure 3A. 
On the other hand, GFP-SC35 was slightly less mobile in 
telophase nuclei than in MIGs or speckles and this trend was 
signifi cant (P<0.001).
We explored the effects of inhibitors of protein 
phosphorylation by cdks on GFP-SC35 distribution and 
dynamics. In interphase cells, when several cdks are 
normally active, treatment with specifi c inhibitors of cdks, 
roscovitine or olomoucine (Meijer et al 1997), caused 
enlargement of GFP-SC35 speckles (fi gure 4A) and these 
speckles colocalized with SC35 labelled with a mAb to 
SC35 (fi gure 4B). On the other hand, cells treated with iso-
olomoucine as a negative control displayed normal speckles. 
GFP-SC35 fl uorescence was also observed at the periphery 
of the nucleolus in treated cells, as reported previously 
for SF2/ASF (Bubulya et al 2004). Immunostaining with 
Figure 3. Fluorescence recovery after photobleaching (FRAP) analysis of green fl uorescent protein (GFP)-SC35. (A) Fluorescence 
images of FRAP processes of GFP-SC35 for the indicated conditions. Circles indicate areas of bleaching where fl uorescence recovery 
was measured. Two example time points are shown at 15 and 40 s after photobleaching. Bar, 5 µm. (B, C) Graphical presentation of 
fl uorescence recovery as change in relative fl uorescence intensity (RFI) over time (post-bleach as zero) for (B) metaphase cytoplasm 
(circles) and interphase speckles (squares); (C) interphase speckles (circles) and roscovitine-treated interphase speckles (squares). The data 
for interphase speckles (not treated with roscovitine) are shown in both (B) and (C) for easy comparison.
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an antibody to fi brillarin revealed that it was dispersed 
in treated cells (fi gure 4B). To determine whether SC35 
can be phosphorylated by a cdk, we checked the ability 
of Cdk1 to phosphorylate SC35 in vitro, since purifi ed, 
active Cdk1–cyclin B1 complex is available commercially. 
Purifi ed glutathione S-transferase (GST)-tagged SC35 was 
incubated with Cdk1–cyclin B1 in the presence of γ32P-
ATP. As shown in fi gure 4, SC35 was phosphorylated by 
Cdk1–cyclin B1 whereas no phosphorylation was observed 
in a control reaction with buffer alone. Purifi ed GST was not 
phosphorylated by Cdk1–cyclin B1 (data not shown). We 
further confi rmed that RNA polymerase II transcription was 
inhibited by roscovitine and olomoucine (data not shown). 
As the speckles enlarged in interphase nuclei after 
roscovitine or olomoucine treatment, we were interested 
in analysing the dynamics of GFP-SC35 in these domains. 
FRAP analysis in roscovitine-treated interphase cells 
indicated that GFP-SC35 in enlarged speckles became 
slightly more mobile than in normal interphase speckles 
with a t½ of ~1.7 s (fi gure 3 and table 1). Though the 
difference was small, the trend was signifi cant (P<0.001). 
The full fl uorescence recovery of GFP-SC35 approached 
100%, demonstrating that almost all GFP-SC35 within 
the bleached region was replaceable. Similar results were 
obtained with GFP-SF2/ASF in interphase speckles after 
roscovitine treatment. As we had noted that the nucleolar 
protein fi brillarin was dispersed in interphase cells after 
treatment with roscovitine (see fi gure 4C), we also analysed 
the dynamics of fi brillarin under these conditions. FRAP 
analysis of GFP-fi brillarin within the nucleolus indicated 
that its mobility was slow in this compartment (D=0.047 
µm2/s), which was consistent with an earlier report (Phair 
and Misteli 2000). However, GFP-fi brillarin became 2-fold 
more mobile after roscovitine treatment (P<0.001), with 
a reduction in the immobile fraction in the nucleolus, as 
shown in fi gure 5 and table 1. 
Table 1. Fluorescence recovery after photobleaching (FRAP) 
analysis of SC35, SF2/alternate splicing factor (ASF) and 
fi brillarin
Bleached compartment
Half time 
(t½) (s)
Diffusion 
coeffi cient
(µm2/s)
SC35 in interphase speckles 2.21 ± 0.54 0.237
SC35 in interphase nucleoplasm 2.10 ± 0.61 0.245
SF2/ASF in interphase speckles 2.27 ± 0.51 0.235
SC35 in metaphase cytoplasm 0.71 ± 0.08 0.887
SC35 in telophase MIGs 2.31 ± 0.47 0.235
SC35 in telophase nuclei 2.97 ± 0.71 0.189
SC35 in interphase speckles 
+ roscovitine
1.70 ± 0.24 0.333
SC35 in interphase nucleoplasm 
+ roscovitine
2.50 ± 0.51 0.222
SF2/ASF in interphase speckles 
+ roscovitine
1.63 ± 0.22 0.341
Fibrillarin in nucleolus 17.5 ± 3.25 0.047
Fibrillarin in nucleolus 
+ roscovitine
7.74 ± 1.57 0.088
Figure 4. Effects of cdk inhibitors on green fl uorescent protein 
(GFP)-SC35 and nuclear markers. (A) HeLa cells expressing GFP-
SC35 were treated with roscovitine, olomoucine or iso-olomoucine. 
(B) HeLa cells expressing GFP-SC35 were treated with roscovitine 
and stained with antibodies to SC35 or fi brillarin (optical sections 
of 0.5 µm). Arrows point to GFP-SC35 localized near the nucleolus 
after drug treatment. Bar, 10 µm. (C) In vitro kinase assays of 
purifi ed GST-SC35, with or without Cdk1–cyclin B1, showing the 
phosphorimager analysis of radioactive phosphorylation (Ph) and 
the Coomassie blue-stained gel (CB).
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4. Discussion
During mitosis, nuclear speckles are disassembled in 
metaphase and reassembled in telophase as MIGs (Reuter 
et al 1985; Verheijen et al 1986; Leser et al 1989; Spector 
et al 1991; Ferreira et al 1994). We observed that a 
substantial fraction of GFP-SC35 was localized within 
telophase nuclei after the formation of the nascent nuclear 
envelope, while a comparatively smaller amount was 
present in MIGs. This distribution is distinct from that 
reported for the splicing factors SF2/ASF or B”, which are 
highly enriched in MIGs in telophase (Prasanth et al 2003). 
The difference in reactivity with a mAb to SC35 suggests 
that the SC35 present within telophase nuclei might be in 
a hypophosphorylated or differentially phosphorylated form 
compared with the hyperphosphorylated form of SC35 
in MIGs. Nuclear speckles are reassembled in G1 nuclei 
after transient accumulation of splicing factors in patches 
around active nucleolar organizing regions (NORs) termed 
NOR-associated patches (NAPs) in telophase nuclei, and 
a hypophosphorylated form of SC35 has been detected 
in NAPs (Bubulya et al 2004). The different components 
of the transcription and pre-mRNA splicing machinery 
show differences in their order of nuclear entry during 
reformation of the nucleus; based on the observed entry of 
splicing factors into telophase nuclei with their concomitant 
reduction in MIGs, it has been suggested that MIGs may 
serve as recruitment or sites for modifi cation of splicing 
factors (possibly by phosphorylation) before their migration 
into telophase nuclei (Prasanth et al 2003).
It has been earlier demonstrated that GFP-SF2/ASF 
rapidly associates with and dissociates from nuclear 
speckles, and shows similar diffusion coeffi cients for 
molecules residing in the nucleoplasm or speckles (Phair 
and Misteli 2000). In our study, we also obtained similar 
values for GFP-SC35 in interphase cells. Interestingly, 
in metaphase cells, GFP-SC35 moves more rapidly than 
in the interphase nucleoplasm, indicating that its binding 
interactions in these two compartments are different. 
Furthermore, our data suggest that the mobility of GFP-
SC35 in MIGs is similar to that in interphase speckles or 
nucleoplasm, in accordance with the view that MIGs are 
functional counterparts of interphase speckles (Prasanth et 
al 2003). The observed slower mobility of GFP-SC35 in 
telophase nuclei might be a consequence of the crowded 
environment of telophase chromatin. The slightly faster 
mobility of GFP-SC35 in enlarged speckles in interphase 
cells treated with cdk inhibitors is probably due to the 
absence of nucleoplasmic binding sites for GFP-SC35 at 
transcription centres, as roscovitine has been observed to 
inhibit transcription by inhibiting phosphorylation of the 
carboxyl-terminal domain of RNA polymerase II (Ljungman 
and Paulsen 2001). A similar increase in mobility has been 
reported with GFP-SF2/ASF in cells treated with the 
transcriptional inhibitor α-amanitin (Phair and Misteli 2000). 
In view of the observed phosphorylation of SC35 by Cdk1 
in vitro, another potential mechanism is that cdk inhibitors 
might block the phosphorylation of SC35 and thereby hinder 
its recruitment to transcription sites. This is in accordance 
with the well documented requirement for phosphorylation 
of splicing factors to enable their recruitment to transcription 
sites (Misteli et al 1998).
We observed that treatment of cells with roscovitine leads 
to dispersal of the nucleolar protein fi brillarin in interphase 
cells, with a concomitant increase in mobility. This increase 
in mobility may refl ect the absence of appropriate binding 
Figure 5. Fluorescence recovery after photobleaching (FRAP) 
analysis of green fl uorescent protein (GFP)-fi brillarin. (A, B) 
Fluorescence images of FRAP processes of GFP-fi brillarin in 
untreated and roscovitine-treated interphase cells. Circles indicate 
areas of bleaching where fl uorescence recovery was measured. Two 
example time points are shown at 15 and 40 s after photobleaching. 
Bar, 5 µm. (C) Graphical presentation of fl uorescence recovery as 
relative fl uorescence intensity (RFI) over time.
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sites for fi brillarin after disorganization of the nucleolar 
compartment due to treatment with roscovitine. Fibrillarin is 
involved in the processing of rRNA transcripts and interacts 
with U3 small nucleolar RNA (snoRNA) (Scheer and Hock 
1999). Consistent with a requirement for phosphorylation of 
regulatory factors by cdks to increase rDNA transcription 
(Voit et al 1999), treatment with the cdk inhibitor roscovitine 
causes disorganization of nucleoli (Sirri et al 2002).
In summary, the dynamics of splicing factor SC35 
depend on the nuclear compartment in which it is localized, 
particularly in mitotic cells. Furthermore, the mobilities 
of both GFP-SC35 and GFP-fi brillarin are altered in 
the presence of a cdk inhibitor in interphase cells. Our 
results have important implications for understanding how 
activities of individual components are directed by nuclear 
compartmentalization.
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